151 related articles for article (PubMed ID: 18777501)
1. PPAR-gamma2 Pro12Ala polymorphism in the population of obese and non-obese men of the city of Wroclaw.
Kuliczkowska J; Filus A; Trzmiel A; Tworowska U; Demissie M; Jedrzejuk D; Milewicz A
Endokrynol Pol; 2008; 59(4):312-5. PubMed ID: 18777501
[TBL] [Abstract][Full Text] [Related]
2. Relationship of PPARgamma2 polymorphism with obesity and metabolic syndrome in postmenopausal Polish women.
Milewicz A; Tworowska-Bardziñska U; Dunajska K; Jêdrzejuk D; Lwow F
Exp Clin Endocrinol Diabetes; 2009 Nov; 117(10):628-32. PubMed ID: 19609844
[TBL] [Abstract][Full Text] [Related]
3. Association of pro12Ala polymorphism in the peroxisome proliferative-activated receptor gamma2 gene with obesity and hypertension in Korean women.
Kim K; Lee S; Valentine RJ
J Nutr Sci Vitaminol (Tokyo); 2007 Jun; 53(3):239-46. PubMed ID: 17874829
[TBL] [Abstract][Full Text] [Related]
4. Association between Pro12Ala polymorphism of the PPAR-gamma2 gene and insulin sensitivity in Brazilian patients with type-2 diabetes mellitus.
Tavares V; Hirata RD; Rodrigues AC; Monte O; Salles JE; Scalissi N; Speranza AC; Hirata MH
Diabetes Obes Metab; 2005 Sep; 7(5):605-11. PubMed ID: 16050954
[TBL] [Abstract][Full Text] [Related]
5. [Is obesity associated with a polymorphism Pro12Ala and Pro115Gln in the PPARgamma gene?].
Bidzińska B; Demissie M; Tworowska U; Slezak R; Dobosz T; Milewicz A
Pol Merkur Lekarski; 2004 Oct; 17(100):361-4. PubMed ID: 15690702
[TBL] [Abstract][Full Text] [Related]
6. [Is obesity associated with a polymorphism Pro12Ala and Pro115Gln in PPARgamma gene?].
Bidzińska B; Demissie M; Tworowska U; Slezak R; Dobosz T; Milewicz A
Pol Merkur Lekarski; 2004 May; 16(95):434-7. PubMed ID: 15518421
[TBL] [Abstract][Full Text] [Related]
7. Effects of two common polymorphisms of peroxisome proliferator-activated receptor-gamma gene on metabolic syndrome.
Rhee EJ; Oh KW; Lee WY; Kim SY; Oh ES; Baek KH; Kang MI; Kim SW
Arch Med Res; 2006 Jan; 37(1):86-94. PubMed ID: 16314192
[TBL] [Abstract][Full Text] [Related]
8. PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity in childhood obesity.
Buzzetti R; Petrone A; Caiazzo AM; Alemanno I; Zavarella S; Capizzi M; Mein CA; Osborn JA; Vania A; di Mario U
Pediatr Res; 2005 Jan; 57(1):138-40. PubMed ID: 15531738
[TBL] [Abstract][Full Text] [Related]
9. [Leptin level and the PPARgamma2 Pro12Ala and Pro115Gln polymorphisms in women with functional hyperandrogenism. Preliminary report].
Bidzińska-Speichert B; Demissie M; Tworowska U; Slezak R; Dobosz T; Bednarek-Tupikowska G; Milewicz A
Przegl Lek; 2005; 62(9):833-7. PubMed ID: 16541712
[TBL] [Abstract][Full Text] [Related]
10. PPAR-gamma2 pro12Ala polymorphism is associated with post-challenge abnormalities of glucose homeostasis in children and adolescents with obesity.
Jermendy A; Körner A; Kovács M; Madácsy L; Cseh K
J Pediatr Endocrinol Metab; 2011; 24(1-2):55-9. PubMed ID: 21528816
[TBL] [Abstract][Full Text] [Related]
11. Effects of Pro12Ala polymorphism in peroxisome proliferator-activated receptor-γ2 gene on metabolic syndrome risk: a meta-analysis.
Zhang R; Wang J; Yang R; Sun J; Chen R; Luo H; Liu D; Cai D
Gene; 2014 Feb; 535(1):79-87. PubMed ID: 24012868
[TBL] [Abstract][Full Text] [Related]
12. Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population.
González Sánchez JL; Serrano Ríos M; Fernández Perez C; Laakso M; Martínez Larrad MT
Eur J Endocrinol; 2002 Oct; 147(4):495-501. PubMed ID: 12370112
[TBL] [Abstract][Full Text] [Related]
13. D2 Thr92Ala and PPARγ2 Pro12Ala polymorphisms interact in the modulation of insulin resistance in type 2 diabetic patients.
Estivalet AA; Leiria LB; Dora JM; Rheinheimer J; Bouças AP; Maia AL; Crispim D
Obesity (Silver Spring); 2011 Apr; 19(4):825-32. PubMed ID: 20930717
[TBL] [Abstract][Full Text] [Related]
14. Effect of the Pro12Ala polymorphism of the PPAR gamma 2 gene on response to pioglitazone treatment in menopausal women.
Ramírez-Salazar M; Pérez-Luque E; Fajardo-Araujo M; Garza SM; Malacara JM
Menopause; 2008; 15(6):1151-6. PubMed ID: 18551086
[TBL] [Abstract][Full Text] [Related]
15. Lack of association between the Pro12Ala polymorphism in PPAR-gamma2 gene and body weight changes, insulin resistance and chronic diabetic complications in obese patients with type 2 diabetes.
Stefanski A; Majkowska L; Ciechanowicz A; Frankow M; Safranow K; Parczewski M; Pilarska K
Arch Med Res; 2006 Aug; 37(6):736-43. PubMed ID: 16824933
[TBL] [Abstract][Full Text] [Related]
16. [Effect of gene polymorphism of PPARgamma2 regulatory proteins on the metabolic syndrome in children with nonalcoholic fatty liver disease and obesity].
Georgian Med News; 2014 Apr; (229):66-73. PubMed ID: 24850609
[TBL] [Abstract][Full Text] [Related]
17. Analysis of candidate genes in Polish families with obesity.
Malczewska-Malec M; Wybranska I; Leszczynska-Golabek I; Partyka L; Hartwich J; Jabrocka A; Kiec-Wilk B; Kwasniak M; Motyka M; Dembinska-Kiec A
Clin Chem Lab Med; 2004 May; 42(5):487-93. PubMed ID: 15202783
[TBL] [Abstract][Full Text] [Related]
18. A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity.
Swarbrick MM; Chapman CM; McQuillan BM; Hung J; Thompson PL; Beilby JP
Eur J Endocrinol; 2001 Mar; 144(3):277-82. PubMed ID: 11248748
[TBL] [Abstract][Full Text] [Related]
19. Association of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma2 gene with small dense low-density lipoprotein in the general population.
Hamada T; Kotani K; Tsuzaki K; Sano Y; Murata T; Tabata M; Sato S; Sakane N
Metabolism; 2007 Oct; 56(10):1345-9. PubMed ID: 17884443
[TBL] [Abstract][Full Text] [Related]
20. The Pro12Ala polymorphism of the PPAR gamma 2 gene influences sex hormone-binding globulin level and its relationship to the development of the metabolic syndrome in young Finnish men.
Mousavinasab F; Tähtinen T; Jokelainen J; Koskela P; Vanhala M; Oikarinen J; Laakso M; Keinänen-Kiukaanniemi S
Endocrine; 2006 Oct; 30(2):185-90. PubMed ID: 17322577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
